Illumina Stock News

Over the past 3 months, 5 analysts have published their opinion on Illumina (NASDAQ: ILMN ) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company''s business to predict how a stock will trade over the upcoming year. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 0 0 4 1 0 Last 30D 0 0 1 0 0 1M Ago 0 0 1 0 0 2M Ago 0 0 2 1 0 3M Ago 0 0 0 0 0 In the last 3 months, 5 analysts have offered 12-month price targets for Illumina. The company has an average price target of $394.0 with a high of $430.00 … Full story available on Benzinga.com

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Adcom Rules That Lilly May Have To Conduct Additional Studies For Co-Developed Oncology Drug Eli Lilly

Record shipments for both clinical and research with strength in oncology testing, genetic disease testing, and population genomics drove Illumina (ILMN) Q4 revenues.

SVB Leerink cut Illumina, Inc. (NASDAQ: ILMN) price target from $430 to $400. Illumina shares fell 0.7% to $355.70 in pre-market trading. Canaccord Genuity lowered Aspen Group, Inc. (NASDAQ: ASPU)

Pre-open movers U.S. stock futures traded lower in early pre-market trade after the Dow Jones tumbled more than 500 points in the previous session. Investors are awaiting earnings results from The Go

Illumina Inc (NASDAQ: ILMN ) reported Q4 revenues of $1.19 billion , +26% Y/Y, beating the consensus of $ $1.13 billion. Product revenues were $1.07 billion, up 28%, and service & other revenues were $133 million, up 9%. "We are seeing strength across our business as a growing number of patients around the world are accessing the life-saving benefits of genomics, … Full story available on Benzinga.com

Record shipments for both clinical and research with strength in oncology testing, genetic disease testing, and population genomics drove Illumina (ILMN) Q4 revenues.

Some of the stocks that may grab investor focus today are: Wall Street expects The Goodyear Tire & Rubber Company (NASDAQ: GT) to report quarterly earnings at $0.32 per share on revenue of $4.96 bi

Illumina, Inc. (NASDAQ: ILMN) Q4 2021 earnings call dated Feb. 10, 2022 Presentation: Operator Good day, ladies and gentlemen, and welcome to the Fourth Quarter 2021 Illumina Earnings Conference Call. […] The post Illumina, Inc. (ILMN) Q4 2021 Earnings Call Transcript first appeared on AlphaStreet .

Illumina stock slid despite an earnings beat, and preannounced strong revenue. It got off easy for a biotech company.

Illumina (ILMN) delivered earnings and revenue surprises of 50% and 0.75%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Although Illumina''s Q4 2021 net income plummeted 56% to $112M compared to the prior-year period, that was good enough to beat expectations.

Illumina press release (ILMN): Q4 Non-GAAP EPS of $0.75 beats by $0.26.Revenue of $1.19B (+24.9% Y/Y) beats by $70M.Cash flow from operations of $282 million compared to $406 million…

Illumina Earnings, Revenue Beat in Q4